Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems SerologyAmy W. Chung, Galit Alter, Manu P. Kumar et al.|Cell|2015Cited by 366
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch, Ludo Lavreys, David C. Montefiori et al.|The Lancet|2018Cited by 342
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trialMorgane Rolland, James I. Mullins, Sodsai Tovanabutra et al.|Nature Medicine|2011Cited by 227
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trialShuying S. Li, Daniel E. Geraghty, Peter B. Gilbert et al.|Journal of Clinical Investigation|2014Cited by 109
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)Dan H. Barouch, Lindsey R. Baden, Jinyan Liu et al.|The Journal of Infectious Diseases|2012Cited by 107